Literature DB >> 6430801

Differential effects of putative lipoxygenase inhibitors on arachidonic acid metabolism in cell-free and intact cell preparations.

J Chang, M D Skowronek, M L Cherney, A J Lewis.   

Abstract

The effects of nordihydroguairetic acid (NDGA), 3-amino-1-trifluoromethyl-)-phenyl-2-pyrazoline (BW755c), eicostatetraynoic acid (ETYA), phenidone, quercetin, and indomethacin (INDO) on the synthesis of 15-hydroxyeicosatatetraenoic acid (15-HETE) from soybean 15-lipoxygenase, leukotriene B4 (LTB4) from 5-lipoxygenase, and prostaglandin E2 (PGE2) from cyclooxygenase enzymes of rat neutrophils and mouse peritoneal macrophages were investigated. All of the drugs caused a dose-related inhibition of increased oxygen consumption by soybean 15-lipoxygenase in the presence of arachidonic acid and the rank order of potency was phenidone greater than or equal to BW755c greater than ETYA greater than quercetin greater than NDGA greater than indomethacin. The reduction in oxygen consumption correlated with a reduction of 15-HETE formation as identified by high-performance liquid chromatography. Apart from indomethacin, these drugs were also effective against the rat neutrophil 5-lipoxygenase, although the rank order of potency did not correlate with that obtained with soybean 15-lipoxygenase. Furthermore, in both A23187-activated rat neutrophils and zymosan-activated mouse peritoneal macrophages the synthesis of prostaglandins was inhibited by all of these drugs. In the neutrophils, the rank order of potency was INDO greater than ETYA greater than BW755c greater than quercetin greater than NDGA greater than phenidone, whereas in mouse peritoneal macrophages, the order was INDO greater than ETYA greater than BW755c greater than NDGA greater than quercetin greater than phenidone. These results suggest that putative lipoxygenase inhibitors exhibit both qualitative and quantitative differences in their effects on both lipoxygenases and cyclooxygenases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430801     DOI: 10.1007/bf00916090

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  A new approach to anti-inflammatory drugs.

Authors:  G A Higgs; R J Flower; J R Vane
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

2.  Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung.

Authors:  C L Armour; J M Hughes; J P Seale; D M Temple
Journal:  Eur J Pharmacol       Date:  1981-06-10       Impact factor: 4.432

3.  A rapid method for detecting inhibitors of both cyclo-oxygenase lipoxygenase metabolites of arachidonic acid.

Authors:  J Harvey; D J Osborne
Journal:  J Pharmacol Methods       Date:  1983-04

4.  Leukotrienes and slow reacting substance of anaphylaxis (SRS-A).

Authors:  B Samuelsson; S Hammarström; R C Murphy; P Borgeat
Journal:  Allergy       Date:  1980-07       Impact factor: 13.146

5.  Interactions of sulfhydryl agents and soybean lipoxygenase inhibitors.

Authors:  I Knippel; J Baumann; F von Bruchhausen; G Wurm
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

6.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

7.  Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids.

Authors:  E J Goetzl; A R Brash; A I Tauber; J A Oates; W C Hubbard
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

8.  1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets.

Authors:  G J Blackwell; R J Flower
Journal:  Prostaglandins       Date:  1978-09

9.  Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro.

Authors:  C J Hanna; M K Bach; P D Pare; R R Schellenberg
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

10.  The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities.

Authors:  J Robak; Z Duniec
Journal:  Biochem Pharmacol       Date:  1982-06-01       Impact factor: 5.858

View more
  16 in total

1.  Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells.

Authors:  April N Meyer; Christopher W McAndrew; Daniel J Donoghue
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

Review 2.  Non-parenchymal cells as mediators of physiological responses in liver.

Authors:  J G Altin; F L Bygrave
Journal:  Mol Cell Biochem       Date:  1988-09       Impact factor: 3.396

3.  Alterations in neutrophil superoxide production following piroxicam therapy in patients with rheumatoid arthritis.

Authors:  D E Van Epps; S Greiwe; J Potter; J Goodwin
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

4.  Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation.

Authors:  R P Carlson; L O'Neill-Davis; W Calhoun; L Datko; J H Musser; A F Kreft; J Y Chang
Journal:  Agents Actions       Date:  1989-03

5.  The inhibition of 5-lipoxygenase by RG 6866.

Authors:  G W Carnathan; D M Sweeney; J J Travis; R J Gordon; C A Sutherland; N Jariwala; M Clearfield; S O'Rourke; F C Huang; R G Van Inwegen
Journal:  Agents Actions       Date:  1989-11

6.  The action of extracellular NAD+ on gluconeogenesis in the perfused rat liver.

Authors:  Adriana G Martins; Jorgete Constantin; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

7.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

8.  Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs.

Authors:  K Sekizawa; G H Caughey; S C Lazarus; W M Gold; J A Nadel
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

9.  Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs.

Authors:  Joseph E Blecha; Marc O Anderson; Jennifer M Chow; Christle C Guevarra; Celia Pender; Cristina Penaranda; Marianna Zavodovskaya; Jack F Youngren; Clifford E Berkman
Journal:  Bioorg Med Chem Lett       Date:  2007-04-29       Impact factor: 2.823

10.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.